- Home
- RPRX vs FRMI Comparison
RPRX vs FRMI Comparison
Compare RPRX & FRMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- FRMI
- Stock Information
- Founded
- RPRX 1996
- FRMI 2025
- Country
- RPRX United States
- FRMI United States
- Employees
- RPRX N/A
- FRMI N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- FRMI Real Estate Investment Trusts
- Sector
- RPRX Health Care
- FRMI Real Estate
- Exchange
- RPRX Nasdaq
- FRMI Nasdaq
- Market Cap
- RPRX 16.2B
- FRMI 14.1B
- IPO Year
- RPRX 2020
- FRMI 2025
- Fundamental
- Price
- RPRX $39.71
- FRMI $15.79
- Analyst Decision
- RPRX Strong Buy
- FRMI Strong Buy
- Analyst Count
- RPRX 3
- FRMI 7
- Target Price
- RPRX $46.00
- FRMI $30.86
- AVG Volume (30 Days)
- RPRX 4.5M
- FRMI 4.2M
- Earning Date
- RPRX 11-05-2025
- FRMI 11-10-2025
- Dividend Yield
- RPRX 2.21%
- FRMI N/A
- EPS Growth
- RPRX N/A
- FRMI N/A
- EPS
- RPRX 1.75
- FRMI N/A
- Revenue
- RPRX $2,349,844,000.00
- FRMI N/A
- Revenue This Year
- RPRX $36.16
- FRMI N/A
- Revenue Next Year
- RPRX $2.04
- FRMI N/A
- P/E Ratio
- RPRX $22.74
- FRMI N/A
- Revenue Growth
- RPRX 3.70
- FRMI N/A
- 52 Week Low
- RPRX $24.05
- FRMI $12.88
- 52 Week High
- RPRX $41.24
- FRMI $36.99
- Technical
- Relative Strength Index (RSI)
- RPRX 59.32
- FRMI N/A
- Support Level
- RPRX $37.31
- FRMI N/A
- Resistance Level
- RPRX $40.00
- FRMI N/A
- Average True Range (ATR)
- RPRX 1.03
- FRMI 0.00
- MACD
- RPRX -0.03
- FRMI 0.00
- Stochastic Oscillator
- RPRX 85.66
- FRMI 0.00
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About FRMI Fermi Inc.
Fermi Inc is an energy and hyperscaler development company purpose-built for the AI era. Its Project Matador, a multi-gigawatt energy and data center development campus designed to support the accelerating needs of to-be-built AI infrastructure. Through its REIT structure, Fermi offers investors exposure to AI infrastructure growth and long-term, large-scale and reliable energy development in a tax-efficient public vehicle.